Device type · KYF
Implant, Eye Valve
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KYF
Ophthalmic
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
266
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Implant, Eye Valve
- Product code
- KYF
- Device class
- Class II
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.3920
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for KYF
Latest FDA decisions
K230975 · Decided May 12, 2023 · 37 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K231051 · Decided May 12, 2023 · 29 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K220032 · Decided Aug 2, 2022 · 209 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K182518 · Decided Jan 18, 2019 · 127 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K171451 · Decided Aug 8, 2017 · 83 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
K161457 · Decided Nov 21, 2016 · 179 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
- Ahmed Glaucoma Valve510(k)
K162060 · Decided Oct 24, 2016 · 90 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
Innovative Ophthalmic Products, Inc. (Iop)
K152996 · Decided Dec 17, 2015 · 65 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
Reports received
266
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
101
38% of reports
Injury reports
164
62% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 12 | 6 | 0 | 0 |
| Jan 24 | 14 | 5 | 0 | 0 |
| Feb 24 | 9 | 18 | 0 | 0 |
| Mar 24 | 14 | 10 | 0 | 0 |
| Apr 24 | 9 | 10 | 0 | 0 |
| May 24 | 6 | 15 | 0 | 0 |
| Jun 24 | 17 | 22 | 0 | 0 |
| Jul 24 | 10 | 31 | 0 | 0 |
| Aug 24 | 11 | 46 | 0 | 0 |
| Sep 24 | 11 | 31 | 0 | 0 |
| Oct 24 | 6 | 23 | 0 | 0 |
| Nov 24 | 7 | 22 | 0 | 0 |
| Dec 24 | 9 | 8 | 0 | 0 |
| Jan 25 | 16 | 10 | 0 | 0 |
| Feb 25 | 3 | 19 | 0 | 0 |
| Mar 25 | 7 | 9 | 0 | 0 |
| Apr 25 | 12 | 12 | 0 | 0 |
| May 25 | 9 | 9 | 0 | 0 |
| Jun 25 | 10 | 21 | 0 | 0 |
| Jul 25 | 11 | 12 | 0 | 0 |
| Aug 25 | 16 | 6 | 0 | 0 |
| Sep 25 | 8 | 12 | 0 | 0 |
| Oct 25 | 12 | 21 | 0 | 0 |
| Nov 25 | 9 | 16 | 0 | 0 |
| Dec 25 | 9 | 12 | 0 | 0 |
| Jan 26 | 6 | 28 | 0 | 0 |
| Feb 26 | 11 | 11 | 0 | 0 |
| Mar 26 | 20 | 7 | 0 | 0 |
| Apr 26 | 6 | 8 | 0 | 0 |
| May 26 | 7 | 12 | 0 | 0 |
| Jun 26 | 5 | 11 | 0 | 0 |
| Jul 26 | 6 | 7 | 0 | 0 |
| Aug 26 | 9 | 14 | 0 | 1 |
| Sep 26 | 10 | 33 | 0 | 0 |
| Oct 26 | 3 | 5 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Glaukos60
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem124
- Physical Resistance/Sticking36
- Break23
- Complete Blockage15
- Migration11
- Device Dislodged or Dislocated10
- Mechanical Jam8
- Appropriate Device Problem Term/Code Not Available7
- Device Appears to Trigger Rejection6
- Fracture6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions100
- Intraocular Pressure Increased51
- Intraocular Pressure Decreased36
- Eye Injury27
- Hyphema19
- Endophthalmitis17
- Visual Impairment15
- Choroidal effusion13
- Corneal Decompensation12
- Loss of Vision12
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0598-2020 · Started Oct 30, 2019
Reason given: Residual polishing compounds, that are used in the needle sleeve manufacturing process, may be present on the injector needle. The residual polishing compounds could transfer to the patient's eye during procedure possibly resulting in irritation, inflammation, local allergic reaction/ hypersensitivity, iritis,...
Cause as FDA categorized it: Vendor change control
Innovative Ophthalmic Products, Inc
Z-1252-2016 · Started Feb 22, 2016
Reason given: Innovative Ophthalmic Products (IOP) is recalling the Molteno 3 G-Series Glaucoma Implant the package insert/Instructions for Use (IFU) for the device has been updated to add a caution statement to minimize off-label use.
Cause as FDA categorized it: Labeling False and Misleading
- Krupin Eye Valve, P/N 6003Terminated
Z-0844-06 · Started Apr 12, 2006 · Posted by FDA May 6, 2006
Reason given: Product may have deformed valves which would cause the valve not to operate properly.
Cause as FDA categorized it: Other
Z-0845-06 · Started Apr 12, 2006 · Posted by FDA May 6, 2006
Reason given: Product may have deformed valves which would cause the valve not to operate properly.
Cause as FDA categorized it: Other
Z-0846-06 · Started Apr 12, 2006 · Posted by FDA May 6, 2006
Reason given: Product may have deformed valves which would cause the valve not to operate properly.
Cause as FDA categorized it: Other
- Valve-EV Glaucoma Ultra-Smooth, P/N 6006Terminated
Z-0847-06 · Started Apr 12, 2006 · Posted by FDA May 6, 2006
Reason given: Product may have deformed valves which would cause the valve not to operate properly.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.